two patients , 54 y-o and 64 y-o females , who underwent laryngo-esophago-thyroidectomy for cervical esophageal cancer or thyroid cancer , had replacement with intravenous l-thyroxine with an initial dose of 100 micrograms/day for 9 and 22 days , respectively .
C0027530
cervical
C0007115
thyroid cancer